Cantor Fitzgerald Reiterates Overweight on Prothena Corp, Maintains $129 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $129.
December 18, 2023 | 2:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst reaffirms an Overweight rating on Prothena Corp with a steady price target of $129, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a reputable analyst like Charles Duncan suggests a strong vote of confidence in Prothena Corp's prospects. Maintaining a high price target of $129 indicates an expectation of the stock's future growth, which could positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100